Arcutis Biotherapeutics (ARQT)
(Delayed Data from NSDQ)
$10.62 USD
-0.11 (-1.03%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $10.60 -0.02 (-0.19%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.49 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | 46.67% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.60 |
Next Year | -1.14 |
EPS (TTM) | -2.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 35.76M | 43.81M | 181.79M | 277.97M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 35.76M | 43.81M | 181.79M | 277.97M |
Low Estimate | 35.76M | 43.81M | 181.79M | 277.97M |
Year ago Sales | 5.19M | 38.11M | 59.61M | 181.79M |
Year over Year Growth Est. | 589.02% | 14.96% | 204.98% | 52.91% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.49 | -0.41 | -1.60 | -1.14 |
# of Estimates | 2 | 1 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.47 | -0.41 | -1.60 | -1.10 |
Low Estimate | -0.50 | -0.41 | -1.60 | -1.17 |
Year ago EPS | -1.16 | -0.73 | -3.78 | -1.60 |
Year over Year Growth Est. | 57.76% | 43.84% | 57.67% | 29.06% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.49 | -0.41 | -1.60 | -1.14 |
7 Days Ago | -0.49 | -0.41 | -1.60 | -1.14 |
30 Days Ago | -0.49 | -0.41 | -1.60 | -1.14 |
60 Days Ago | NA | NA | -2.22 | -1.37 |
90 Days Ago | NA | NA | -2.49 | -1.77 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.49 | -0.41 | -1.60 | -1.14 |
Zacks Consensus Estimate | -0.49 | -0.41 | -1.60 | -1.14 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.72 | -0.73 | -1.16 | NA |
Estimate | -0.60 | -0.65 | -0.90 | -1.22 | NA |
Difference | 0.28 | -0.07 | 0.17 | 0.06 | 0.11 |
Surprise | 46.67% | -10.77% | 18.89% | 4.92% | 14.93% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more